{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T01:05:37Z","timestamp":1711415137305},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:00:00Z","timestamp":1683504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Amiodarone-induced thyrotoxicosis (AIT) is a common condition in patients who are receiving amiodarone for cardiac arrhythmia. This risk is elevated in iodine-deficient regions. Levothyroxine is the standard treatment for patients with hypothyroidism. This investigation is concerned with the evaluation of the possible pharmacokinetic interaction between amiodarone and levothyroxine upon co-therapy in rats and to investigate the cause of thyrotoxicosis. A selective, sensitive and precise RP-HPLC method was developed for the simultaneous determination of levothyroxine and amiodarone in rat plasma. A stationary phase of C18 Xterra RP column and a mobile phase consisting of acetonitrile: acidified water with 0.1% trifluoracetic acid (pH\u2009=\u20094.8) with gradient elution were used. The experiment was conducted at ambient temperature with flow rate of 1.5\u00a0mL\/min for the chromatographic separation and quantitation of the investigated drugs. Protein precipitation with methanol was applied for the analysis of the two drugs in rat plasma. The method was linear over concentration range of 5\u2013200\u00a0\u03bcg\/mL for both levothyroxine and amiodarone. The European Medicines Agency guideline was applied for the validation of the developed bioanalytical method. The method was successfully applied to in vivo pharmacokinetic study in which levothyroxine and amiodarone were quantified in plasma of rats after receiving an oral dose of levothyroxine and amiodarone. After the calculation of the pharmacokinetic parameters, a statistical analysis was performed to elucidate the existence of significant difference between test and control groups in rats. The combination of levothyroxine and amiodarone significantly decreased levothyroxine bioavailability in rats, making the therapeutic drug monitoring mandatory in patients receiving levothyroxine and amiodarone. In addition, the increased clearance of levothyroxine upon the co-administration with amiodarone may explain the reported hypothyroidism.<\/jats:p>","DOI":"10.1093\/chromsci\/bmad034","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T19:03:12Z","timestamp":1683745392000},"page":"287-294","source":"Crossref","is-referenced-by-count":0,"title":["<i>In Vivo<\/i> Evaluation of the Pharmacokinetic Interaction between Levothyroxine and Amiodarone in Rat Plasma: Evaluation of Importance of Therapeutic Drug Monitoring during Co-Therapy"],"prefix":"10.1093","volume":"62","author":[{"given":"Norhan S","family":"AlSawy","sequence":"first","affiliation":[{"name":"Pharmacist at Kasr El-Aini Hospital , Kasr El-Aini St., Cairo 11562 , Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehab F","family":"ElKady","sequence":"additional","affiliation":[{"name":"Pharmaceutical Chemistry Department , Faculty of Pharmacy, , Kasr El-Aini St., Cairo 11562 , Egypt"},{"name":"Cairo University , Faculty of Pharmacy, , Kasr El-Aini St., Cairo 11562 , Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman A","family":"Mostafa","sequence":"additional","affiliation":[{"name":"Pharmaceutical Chemistry Department , Faculty of Pharmacy, , Kasr El-Aini St., Cairo 11562 , Egypt"},{"name":"Cairo University , Faculty of Pharmacy, , Kasr El-Aini St., Cairo 11562 , Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,5,8]]},"reference":[{"issue":"12","key":"2024032511260830200_ref1","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1001\/archinte.160.12.1741","article-title":"Practical guidelines for clinicians who treat patients with amiodarone","volume":"160","author":"Goldschlager","year":"2000","journal-title":"Archives of Internal Medicine"},{"issue":"7","key":"2024032511260830200_ref2","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.amjmed.2004.11.028","article-title":"Amiodarone and the thyroid","volume":"118","author":"Basaria","year":"2005","journal-title":"The American Journal of Medicine"},{"issue":"4","key":"2024032511260830200_ref3","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/0002-9378(95)91498-6","article-title":"Pregnancy outcome after gestational exposure to amiodarone in Canada","volume":"172","author":"Magee","year":"1995","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"2024032511260830200_ref4","first-page":"283","article-title":"The effect of medications on thyroid function tests","volume":"96","author":"Kundra","year":"2012","journal-title":"Medical Clinics"},{"issue":"1","key":"2024032511260830200_ref5","first-page":"17","article-title":"The safe and effective implementation of orthoiodosupplementation in medical practice","volume":"11","author":"Abraham","year":"2004","journal-title":"The Original Internist"},{"issue":"1","key":"2024032511260830200_ref6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3923\/pjbs.2011.1.12","article-title":"Metabolic pathways of tetraidothyronine and triidothyronine production by thyroid gland: A review of articles","volume":"14","author":"Mansourian","year":"2011","journal-title":"Pakistan Journal of Biological Sciences"},{"issue":"2","key":"2024032511260830200_ref7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/thy.1997.7.177","article-title":"Iodine metabolism and thyroid physiology: Current concepts","volume":"7","author":"Cavalieri","year":"1997","journal-title":"Thyroid"},{"issue":"3","key":"2024032511260830200_ref8","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00000441-198609000-00003","article-title":"Effects of amiodarone and desethylamiodarone on pituitary deiodinase activity and thyrotropin secretion in the rat","volume":"292","author":"Safran","year":"1986","journal-title":"The American Journal of the Medical Sciences"},{"issue":"4","key":"2024032511260830200_ref9","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1172\/JCI111313","article-title":"Qualitative and quantitative differences in the pathways of extrathyroidal triiodothyronine generation between euthyroid and hypothyroid rats","volume":"73","author":"Silva","year":"1984","journal-title":"The Journal of Clinical Investigation"},{"issue":"5","key":"2024032511260830200_ref10","first-page":"269","article-title":"Amiodarone-induced thyroid dysfunction in clinical practice","volume":"10","author":"Ursella","year":"2006","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"2","key":"2024032511260830200_ref11","first-page":"240","article-title":"The effects of amiodarone on the thyroid","volume":"22","author":"Martino","year":"2001","journal-title":"Endocrine Reviews"},{"key":"2024032511260830200_ref12","article-title":"Amiodarone-induced thyroid dysfunction: clinical case with literature review","volume":"32","author":"Bogun","year":"2016"},{"issue":"4","key":"2024032511260830200_ref13","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0735-1097(84)80367-8","article-title":"Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects","volume":"3","author":"Zipes","year":"1984","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"2024032511260830200_ref14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12020-016-1199-8","article-title":"The emergence of levothyroxine as a treatment for hypothyroidism","volume":"55","author":"Hennessey","year":"2017","journal-title":"Endocrine"},{"issue":"6","key":"2024032511260830200_ref15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.4158\/1934-2403-8.6.457","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism","volume":"8","author":"Baskin","year":"2002","journal-title":"Endocrine Practice"},{"issue":"2","key":"2024032511260830200_ref16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12325-019-01079-1","article-title":"Levothyroxine formulations: pharmacological and clinical implications of generic substitution","volume":"36","author":"Benvenga","year":"2019","journal-title":"Advances in Therapy"},{"key":"2024032511260830200_ref17","volume-title":"The roles of structural variability and amphiphilicity of TMC278\/rilpivirine in mechanisms of HIV drug resistance avoidance and enhanced oral bioavailability","author":"Frenkel","year":"2009"},{"key":"2024032511260830200_ref18","volume-title":"Stockley's drug interactions","author":"Baxter","year":"2010"},{"issue":"3","key":"2024032511260830200_ref19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/2042018811398516","article-title":"Management of amiodarone-related thyroid problems","volume":"2","author":"Narayana","year":"2011","journal-title":"Therapeutic Advances in Endocrinology and Metabolism"},{"key":"2024032511260830200_ref20","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1590\/S0004-27302005000600010","article-title":"Amiodarone-induced thyroid dysfunction in a tertiary center in South Brazil","volume":"49","author":"Schaan","year":"2005","journal-title":"Arquivos Brasileiros de Endocrinologia & Metabologia"},{"issue":"2","key":"2024032511260830200_ref21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/hrt.79.2.121","article-title":"Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy","volume":"79","author":"Newman","year":"1998","journal-title":"Heart"},{"issue":"4","key":"2024032511260830200_ref22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/0885066613503278","article-title":"Amiodarone-induced thyroid dysfunction","volume":"30","author":"Danzi","year":"2015","journal-title":"Journal of Intensive Care Medicine"},{"issue":"43","key":"2024032511260830200_ref23","doi-asserted-by":"crossref","first-page":"5204","DOI":"10.1039\/D1AY01049B","article-title":"Development and validation of a high-performance liquid chromatography method for levothyroxine sodium quantification in plasma for pre-clinical evaluation of long-acting drug delivery systems","volume":"13","author":"Permana","year":"2021","journal-title":"Analytical Methods"},{"issue":"5","key":"2024032511260830200_ref24","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s00216-010-3705-9","article-title":"Analysis of thyroid hormones in serum by liquid chromatography-tandem mass spectrometry","volume":"397","author":"Wang","year":"2010","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"2024032511260830200_ref25","doi-asserted-by":"crossref","first-page":"122447","DOI":"10.1016\/j.jchromb.2020.122447","article-title":"Rapid determination of thyroid hormones in blood plasma from glaucous gulls and Baikal seals by HybridSPE\u00ae-LC-MS\/MS","volume":"1162","author":"Vike-Jonas","year":"2021","journal-title":"Journal of Chromatography B"},{"issue":"3","key":"2024032511260830200_ref26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1677\/JOE-10-0060","article-title":"An online solid-phase extraction-liquid chromatography-tandem mass spectrometry method to study the presence of thyronamines in plasma and tissue and their putative conversion from 13C6-thyroxine","volume":"206","author":"Ackermans","year":"2010","journal-title":"Journal of Endocrinology"},{"issue":"8","key":"2024032511260830200_ref27","doi-asserted-by":"crossref","first-page":"103300","DOI":"10.1016\/j.arabjc.2021.103300","article-title":"Simultaneous determination of amiodarone, dronedarone, and their principal metabolites in SD rat plasma by UPLC-MS\/MS and its application in pharmacokinetics","volume":"14","author":"Zhang","year":"2021","journal-title":"Arabian Journal of Chemistry"},{"issue":"1","key":"2024032511260830200_ref28","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jpba.2009.08.004","article-title":"Simultaneous measurement of amiodarone and desethylamiodarone in human plasma and serum by stable isotope dilution liquid chromatography\u2013tandem mass spectrometry assay","volume":"51","author":"Kuhn","year":"2010","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"issue":"1\u20132","key":"2024032511260830200_ref29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jchromb.2006.03.038","article-title":"Determination of amiodarone and desethylamiodarone in horse plasma and urine by high-performance liquid chromatography combined with UV detection and electrospray ionization mass spectrometry","volume":"836","author":"Maes","year":"2006","journal-title":"Journal of Chromatography B"},{"issue":"3","key":"2024032511260830200_ref30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/bmc.754","article-title":"A liquid chromatography\u2013mass spectrometry assay method for simultaneous determination of amiodarone and desethylamiodarone in rat specimens","volume":"21","author":"Shayeganpour","year":"2007","journal-title":"Biomedical Chromatography"},{"key":"2024032511260830200_ref31","article-title":"Guideline on bioanalytical method validation. European Medicines Agency, Committee for Medicinal Products for Human Use","author":"EMA","year":"2011"},{"key":"2024032511260830200_ref32","volume-title":"National Formulary (NF 25)","author":"The United States Pharmacopeia (USP 30)","year":"2007","edition":"Asian"}],"container-title":["Journal of Chromatographic Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/chromsci\/article-pdf\/62\/3\/287\/57072767\/bmad034.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/chromsci\/article-pdf\/62\/3\/287\/57072767\/bmad034.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T11:29:01Z","timestamp":1711366141000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/chromsci\/article\/62\/3\/287\/7156950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,8]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,5,8]]},"published-print":{"date-parts":[[2024,3,23]]}},"URL":"https:\/\/doi.org\/10.1093\/chromsci\/bmad034","relation":{},"ISSN":["0021-9665","1945-239X"],"issn-type":[{"value":"0021-9665","type":"print"},{"value":"1945-239X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3]]},"published":{"date-parts":[[2023,5,8]]}}}